Overview
What is Barbara Ann Karmanos Cancer Institute?
Barbara Ann Karmanos Cancer Institute is a leading nonprofit organization based in Detroit, Michigan, with a workforce of 331 employees. Their mission is to make significant strides in cancer care, research, and education through courage, commitment, and compassion. At the institute, researchers delve into all aspects of cancer, from prevention and detection to treatment and causes, encompassing various research areas such as molecular imaging, molecular therapeutics, population studies, and tumor biology & microenvironment. With a focus on cutting-edge research, KCI supports investigators through its core facilities, offering essential infrastructure and expertise. The organization is dedicated to transforming lives and making a lasting impact on cancer care.
Official website here: www.karmanos.org
Is Barbara Ann Karmanos Cancer Institute legitimate?
Barbara Ann Karmanos Cancer Institute is a legitimate nonprofit organization registered as a 501(c)(3) entity. Barbara Ann Karmanos Cancer Institute submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $3,435,423
Professional Fundraising Fees: $171,634
Other Salaries and Wages: $6,691,595
For more financial information, click here
Official website here: www.karmanos.org
What is the mission statement of Barbara Ann Karmanos Cancer Institute?
The Barbara Ann Karmanos Cancer Institute is dedicated to pioneering advancements in cancer care, research, and education. This mission is driven by courage, commitment, and compassion. The institute's investigators engage in various forms of research to prevent, detect, treat, and understand the causes of cancer. Research at the institute is organized within four programs: Molecular Imaging, Molecular Therapeutics, Population Studies and Disparities Research, and Tumor Biology & Microenvironment. The core research facilities at the institute support these programs by providing necessary instrumentation and expertise for cutting-edge research.
Official website here: www.karmanos.org
Who is the CEO of Barbara Ann Karmanos Cancer Institute?
Gerold Bepler Md Phd is the Principal Officer of Barbara Ann Karmanos Cancer Institute. The CEO's salary of Barbara Ann Karmanos Cancer Institute is $0 and their total compensation is $1,389,174.
Official website here: www.karmanos.org
What is the revenue of Barbara Ann Karmanos Cancer Institute?
Barbara Ann Karmanos Cancer Institute's revenue in 2022 was $20,019,808.
Official website here: www.karmanos.org
Who are the executives of Barbara Ann Karmanos Cancer Institute and what are their salaries?
The average compensation at Barbara Ann Karmanos Cancer Institute during 2022 was $30,595. There are 331 employees and 13 volunteers at Barbara Ann Karmanos Cancer Institute.
Here are 28 key members and their salaries (Barbara Ann Karmanos Cancer Institute's CEO's salary is $0 and their total compensation is $1,389,174):
- Philip A Incarnati (Board Member) [Trustee/Director]
- Gerold Bepler Md Ph D (President & Ceo; Secretary) [Trustee/Director]
- Praveen Dalmia (Corp Dir For Radiation Svcs)
- Brian R Gamble (Treasurer And Cfo)
- Scott Mccarter (Vp Information Technology Svc)
- Lauren Lawrence (Vp Karmanos Cancer Network)
- Amy Ryder (Vp Human Resources)
- Evano Piasentin (Acd & Vp Research Admin)
- Matthew Pikos (Director Accounting & Finance)
- Lisa Lange (Vp Clinical Trials)
- Doris Ranski-Zazula (Regional Dir Cancer Svcs)
- Joseph Nugent (Director Information Technology Svcs)
- Christopher Boyce (Regional Dir Cancer Svcs)
- Mark Bitz (Director Information Technology Svcs)
- Ann Schwartz (Vp Res & Adac Affairs/Dep Director)
- Timonthy Monahan (Board Member & Chair) [Trustee/Director]
- Geaneen M Arends (Board Member) [Trustee/Director]
- Jim Bennethum (Board Member) [Trustee/Director]
- Karen Cullen (Board Member) [Trustee/Director]
- David W Drews (Board Member) [Trustee/Director]
- David E Duprey (Board Member) [Trustee/Director]
- Shari Ferber-Kaufman (Board Member) [Trustee/Director]
- Sylvester Hester (Board Member) [Trustee/Director]
- Scott Hunter (Board Member) [Trustee/Director]
- Tom Kalas (Board Member) [Trustee/Director]
- Anil Kumar (Board Member) [Trustee/Director]
- Joseph Uberti Md (Board Member) [Trustee/Director]
- M Roy Wilson Md (Board Member) [Trustee/Director]
Official website here: www.karmanos.org
Where can I find the form 990 for Barbara Ann Karmanos Cancer Institute?
The Barbara Ann Karmanos Cancer Institute’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.karmanos.org
Learn more at the official website: www.karmanos.org
Mission Statement of Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute is a leading organization in the field of cancer care, research, and education. With a mission to transform lives through courage, commitment, and compassion, the institute is dedicated to making strides in the prevention, detection, treatment, and understanding of cancer.
At the heart of Barbara Ann Karmanos Cancer Institute's mission lies cutting-edge research. The institute's investigators engage in various types of research, including basic, clinical, epidemiological, and behavioral studies. Their work is supported by the institute's core research facilities, which provide essential instruments and expertise to help researchers perform groundbreaking work. The research conducted at Barbara Ann Karmanos Cancer Institute is organized into four programs: Molecular Imaging, Molecular Therapeutics, Population Studies and Disparities Research, and Tumor Biology & Microenvironment.
Barbara Ann Karmanos Cancer Institute's researchers are committed to making a difference in the fight against cancer. Their work is focused on improving patient outcomes and advancing the field of oncology. Through their transformative approach, they aim to lead the way in delivering innovative solutions and hope to those affected by cancer.
Impact
This information is meant to be a general summary of Barbara Ann Karmanos Cancer Institute. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
The Barbara Ann Karmanos Cancer Institute is a leader in transformative cancer care, research, and education. Through its courageous commitment and compassionate approach, the Institute conducts various forms of cancer research to advance the prevention, detection, treatment, and understanding of cancer. Their research includes basic, clinical, epidemiological, and behavioral studies, organized within specific programs such as molecular imaging, molecular therapeutics, population studies, disparities research, and tumor biology & microenvironment. By enhancing research capabilities and providing cutting-edge facilities, the Institute plays a vital role in the fight against cancer. Located in Detroit, Michigan, the Barbara Ann Karmanos Cancer Institute is making a significant impact in the field of medical research.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
AFFILIATION REVENUE
Revenue
$10,956,689
MEDICAL SERVICES
Revenue
$137,597
EDUCATION AND SUPPORT
Revenue
$114,458
CORD BANK
Revenue
$70,545
CELL LINES
Revenue
$28,325
Organization Details
Founding Year
1947
Phone
(800) 527-6266
Principal Officer
Gerold Bepler Md Phd
Main Address
4100 JOHN R, DETROIT, MI, 48201
Website
www.karmanos.org
NTEE Category
Code: H30 - Medical research
If you are a representative of Barbara Ann Karmanos Cancer Institute and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.